Analyst Downgrades: Apple Inc., Calithera Biosciences Inc, and Gap Inc

Analysts downwardly revised their ratings on Apple Inc. (NASDAQ:AAPL), Calithera Biosciences Inc (NASDAQ:CALA), and Gap Inc (NYSE:GPS)

by Josh Selway

Published on Nov 10, 2015 at 9:29 AM

Analysts are weighing in on tech mammoth Apple Inc. (NASDAQ:AAPL), pharmaceutical stock Calithera Biosciences Inc (NASDAQ:CALA), and apparel focus Gap Inc (NYSE:GPS). Here's a quick roundup of today's bearish brokerage notes on AAPL, CALA, and GPS.

  • A discouraging note from Credit Suisse has AAPL 1.9% lower ahead of the open. The brokerage firm highlighted the fact the company has cut some of its component orders by as much as 10%, indicating weak demand for the iPhone 6s. This development prompted Credit Suisse to lower its iPhone sales estimates for 2016. Meanwhile, the shares have been making a push for the $125-$130 range, but have so far come up short, closing Monday at $120.57. Options traders, though, have recently taken a liking to Apple Inc. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock boasts a 10-day call/put volume ratio of 2.40, which tops 82% of all other readings from the past year. This indicates a pronounced preference for call buying
  • After getting smashed on MondayCALA is set for another devastating day on the charts, off 9% pre-market following the firm's quarterly results. Leerink has since chimed in, cutting its price target to $13 from $19. The equity finished yesterday at $7.83 -- 61.2% lower year-to-date, and short sellers are throwing a party. Over one-fifth of Calithera Biosciences Inc's float is sold short, representing more than two weeks' worth of buying power, at average daily volumes.  
  • Wedbush dropped its price target on GPS to $27, while Baird and Cowen and Company each lowered theirs to $28, after the company announced disappointing same-store sales for October -- though this isn't anything new for the apparel firm. The retailer also offered up a weaker-than-forecast third-quarter profit estimate, and said quarterly sales dropped 3%. Gap Inc is now set to drop 6.8% at the open -- and at a new three-year low -- which would just add to its 34.2% year-to-date decline, finishing at $27.69 on Monday. In the option pits, traders are ready for the drop. GPS' 50-day put/call volume ratio at the ISE, CBOE, and PHLX comes in at 3.55 -- higher than 92% of all readings from the past year. 
Get the skinny on all the biggest stories of the morning… Sign up now to get Schaeffer's Midday Market Check delivered straight to your inbox!

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....
Tiffany Stock Drops as Takeover Talks Dissipate
LVMH was to acquire Tiffany & Co in a billion-dollar deal
Coty Stock Glows Up with Possible Kardashian Cosmetics Line
The trendy cosmetics company is in talks with reality TV star Kim Kardashian West over a line of beauty products
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.